DANIEL BERRY: Open Payments
NPI 1669431938 · CLYDE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,138 in 113 payments from 25 companies in 2025. Trend: 2023 $2,213 · 2024 $2,791 · 2025 $3,138
Food & beverage: $3,138
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 21 | $804 |
| AstraZeneca Pharmaceuticals LP | 10 | $557 |
| Novo Nordisk Inc | 13 | $274 |
| Otsuka America Pharmaceutical, Inc. | 6 | $208 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $194 |
| Axsome Therapeutics, Inc. | 7 | $189 |
| ABBVIE INC. | 12 | $176 |
| PFIZER INC. | 10 | $141 |
| Alkermes, Inc. | 1 | $128 |
| Abbott Laboratories | 4 | $85 |
Products named: AUSTEDO XR, AIRSUPRA, REXULTI, UZEDY, Kerendia, Auvelity, Wegovy, VRAYLAR.
Industry payments across OH — which companies pay providers there.
